GENETIC MARKERS FOR MACULAR DEGENERATION DISORDER TREATMENT
    3.
    发明申请
    GENETIC MARKERS FOR MACULAR DEGENERATION DISORDER TREATMENT 审中-公开
    遗传标记为恶性恶化症状治疗

    公开(公告)号:US20140336055A1

    公开(公告)日:2014-11-13

    申请号:US14271269

    申请日:2014-05-06

    申请人: SEQUENOM, INC.

    IPC分类号: C12Q1/68

    摘要: Provided in part herein are genetic variations (e.g., single nucleotide polymorphisms) associated with a vascular endothelial growth factor (VEGF) suppression response to an anti-VEGF agent for treatment of a macular degeneration disorder (e.g., age-related macular degeneration (AMD)). Also provided herein are methods for determining a genotype that includes such genetic variations, methods for predicting a VEGF suppression response for a subject according to a genotype, and methods for selecting a treatment suitable for treating a macular degeneration disorder (e.g., wet AMD) for a subject in need thereof according to a genotype.

    摘要翻译: 本文部分提供了与用于治疗黄斑变性疾病(例如年龄相关性黄斑变性(AMD))的抗VEGF剂的血管内皮生长因子(VEGF)抑制反应相关的遗传变异(例如,单核苷酸多态性) )。 本文还提供了确定包括这种遗传变异的基因型的方法,根据基因型预测受试者的VEGF抑制应答的方法,以及用于选择适合治疗黄斑变性病症(例如,湿性AMD)的治疗方法 根据基因型的有需要的受试者。